<scp>PPAR gamma</scp> and <scp>PGC</scp>‐1alpha activators protect against diabetic nephropathy by suppressing the inflammation and <scp>NF</scp>‐<scp>kappaB</scp> activation
Weimin Wang(University of North Carolina at Charlotte)
Cited by 29
Related Papers
Randomized clinical trial of vessel sealing system (LigaSure) in esophagogastric devascularization and splenectomy in patients with portal hypertension
|The American Journal of Surgery|2011|27